Tagged With JPM18

The interface of tech and biotech has the potential to revolutionise healthcare, but there's still something missing

'We can't use old models on new innovation': A top GSK exec says pharma is about to see a massive shift

Big pharma is getting ready to spend tax reform dollars on big deals

The first female big pharma CEO had the perfect response to a question about women in leadership

Wall Street just freaked out about a potential hiccup to a revolutionary gene editing technology -- but it's not as bad as it seems

A biotech founded by a 32-year-old just hit another setback -- and the stock got chopped in half